CUEBIOPHARMA13G

Company

Cue Biopharma, Inc.

Filed

March 11, 2024

Accession Number

0001781002-24-000025

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →